Role of cell cycle regulatory molecules in retinoic acid- and vitamin D3-induced differentiation of acute myeloid leukaemia cells

Cell Proliferation

Volumn 47, Issue 3, 2014, Pages 200-210

  Hu, X T ^a   Zuckerman, K S ^b,c  

^a BARRY UNIVERSITY   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE REGULATORY MOLECULE; COLECALCIFEROL; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE ACTIVATING KINASE; CYCLIN E; MYC PROTEIN; PROTEIN P15; PROTEIN P16; PROTEIN P18; PROTEIN P21; PROTEIN P27; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN REGULATION; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; CHOLECALCIFEROL; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLIN-DEPENDENT KINASES; HUMANS; LEUKEMIA, MYELOID, ACUTE; RECEPTORS, RETINOIC ACID; TRETINOIN;

EID: 84900036420     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12100     Document Type: Article

References (104)

1. Breitman TR, Selonick SE, Collins SJ (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl Acad. Sci. USA 77, 2936-2940.
2. Breitman TR, Collins SJ, Keene BR (1981) Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 57, 1000-1004.
3. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T et al. (1981) Differentiation of mouse myeloid leukemia cells induced by 1-alpha, 25-dihydroxyvitamin D3. Proc. Natl Acad. Sci. USA 78, 4990-4994.
4. Honma Y, Hozumi M, Abe E, Konno K, Fukushima M, Hata S et al. (1983) 1-Alpha, 25-dihydroxyvitamin D3 and 1-alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc. Natl Acad. Sci. USA 80, 201-204.
5. Mangelsdorf D, Koeffler HP, Donaldson C, Pike J, Haussler M (1984) 1, 25-Dihydroxyvitamin D3-induced differentiation in a human promyelocyticleukaemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J. Cell Biol. 98, 391-398.
6. Brown G, Bunce C, Rowlands D, Williams G (1994) All-trans retinoic acid and 1α, 25-di-hydroxyvitaminD3 co-operate to promote differentiation of the human promyeloidleukaemia cell line HL60 to monocytes. Leukemia 8, 806-815.
7. Wang X, Studzinski GP (2001) Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1, 25-dihydroxyvitamin D3-induced differentiation of HL60 cells. J. Cell. Biochem. 80, 471-482.
8. Bobilev I, Novik V, Levi I, Shpilberg O, Levy J, Sharoni Y et al. (2011) The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells. Cancer Biol. Ther. 11, 317-329.
9. Hughes PJ, Steinmeyer A, Chandraratna RA, Brown G (2005) 1alpha, 25-dihydroxyvitamin D3 stimulates steroid sulphatase activity in HL60 and NB4 acute myeloid leukaemia cell lines by different receptor-mediated mechanisms. J. Cell. Biochem. 94, 1175-1189.
10. Jamshidi F, Zhang J, Harrison JS, Wang X, Studzinski GP (2008) Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1, 25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling. Cell Cycle 7, 917-924.
11. Gocek E, Marchwicka A, Baurska H, Chrobak A, Marcinkowska E (2012) Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation. J. Steroid Biochem. Mol. Biol. 132, 220-226.
12. Collins SJ, Robertson KA, Mueller L (1990) Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha). Mol. Cell. Biol. 10, 2154-2163.
13. Robertson KA, Emami B, Collins SJ (1992) Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80, 1885-1889.
14. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A (1991) The PML-RARa fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684.
15. Pandolfi PP, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F et al. (1991) Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid binding and transactivation properties. Oncogene 6, 1285-1292.
16. Zelent A, Guidez F, Melnick A, Waxman S, Licht JD (2001) Translocations of the RARalpha gene in acute promyelocytic leukemia. Oncogene 20, 7186-7203.
17. Salomoni P, Pandolfi PP (2002) The role of PML in tumor suppression. Cell 108, 165-170.
18. Ricote M, Snyder CS, Leung HY, Chen J, Chien KR, Glass CK (2006) Normal hematopoiesis after conditional targeting of RXRalpha in murine hematopoietic stem/progenitor cells. J. Leukoc. Biol. 80, 850-861.
19. Nurse P (2000) A long twentieth century of the cell cycle and beyond. Cell 100, 71-78.
20. Poon RYC, Yamashita K, Adamczewszi JP, Hunt T, Shuttleworth J (1993) The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J. 12, 3123-3132.
21. Solomon MJ, Harper JW, Shuttleworth J (1993) CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12, 3133-3142.
22. Fisher RP, Morgan DO (1994) A novel form of cyclin associates with MO15/CDK7 to from the CDK-activating kinase. Cell 78, 713-724.
23. Matsuoka M, Kato J-Y, Fisher RP, Morgan DO, Sherr CS (1994) Activation of cyclin-dependent kinsase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell. Biol. 14, 7265-7275.
24. Nigg EA (1996) Cyclin-dependent kinase-7: at the cross-roads of transcription, DNA-repair and cell-cycle control. Curr. Opin. Cell Biol. 8, 312-317.
25. Fisher RP, Jin P, Chamberlin HM, Morgan DO (1995) Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83, 47-57.
26. Tassan J-P, Jaquenoud M, Fry AM, Frutiger S, Hughes GJ, Nigg EA (1995) In vitro assembly of a functional human CDK7-cyclin H complex requires MAT1, a novel 36 kDa RING finger protein. EMBO J. 14, 5608-5617.
27. Devault A, Martinez AM, Fesquet D, Labbé JC, Morin N, Tassan JP et al. (1995) MAT1 ('menage á trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J. 14, 5027-5036.
28. Yankulov KY, Bentley DL (1997) Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16, 1638-1646.
29. Wu L, Chen P, Shum CH, Chen C, Barsky LW, Weinberg KI et al. (2001) MAT1-modulated CAK activity regulates cell cycle G(1) exit. Mol. Cell. Biol. 21, 260-270.
30. Rochette-Egly C, Adam S, Rossignol M, Egly JM, Chambon P (1997) Stimulation of RAR alpha activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90, 97-107.
31. Bour G, Gaillard E, Bruck N, Lalevée S, Plassat JL, Busso D et al. (2005) Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. Proc. Natl Acad. Sci. USA 102, 16608-16613.
32. Rossi DJ, Londesborough A, Korsisaari N, Pihlak A, Lehtonen E, Henkemeyer M et al. (2001) Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1. EMBO J. 20, 2844-2856.
33. Wang J, Barsky LW, Shum CH, Jong A, Weinberg KI, Collins SJ et al. (2002) Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor. J. Biol. Chem. 277, 43369-43376.
34. Chaudhry P, Yang X, Wagner M, Jong A, Wu L (2012) Retinoid-regulated FGF8f secretion by osteoblasts bypasses retinoid stimuli to mediate granulocytic differentiation of myeloid leukemia cells. Mol. Cancer Ther. 11, 267-276.
35. Melnick A, Licht JD (1999) Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93, 3167-3215.
36. Jing Y, Xia L, Lu M, Waxman S (2003) The cleavage product DPML-RARa contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells. Oncogene 22, 4083-4091.
37. Pitha-Rowe I, Petty WJ, Kitareewan S, Dmitrovsky E (2003) Retinoid target genes in acute promyelocytic leukemia. Leukemia 17, 1723-1730.
38. He Q, Peng H, Collines SJ, Triche TJ, Wu L (2004) Retinoid-modulated MAT1 ubiquitination and CAK activity. FASEB J. 18, 1734-1736.
39. Wang A, Alimova IN, Luo P, Jong A, Triche TJ, Wu L (2010) Loss of CAK phosphorylation of RAR{alpha} mediates transcriptional control of retinoid-induced cancer cell differentiation. FASEB J. 24, 833-843.
40. Hu X, Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402, 93-96.
41. Hurst RJ, Else KJ (2012) Retinoic acid signalling in gastrointestinal parasite infections: lessons from mouse models. Parasite Immunol. 34, 351-359.
42. Kopf E, Plassat JL, Vivat V, de The H, Chambon P, Rochette-Egly C (2000) Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J. Biol. Chem. 275, 33280-33288.
43. Bastien J, Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328, 1-16.
44. de Thé H, Le Bras M, Lallemand-Breitenbach V (2012) The cell biology of disease: acute promyelocytic leukemia, arsenic, and PML bodies. J. Cell Biol. 198, 11-21.
45. Zhang S, He Q, Peng H, Tedeschi-Blok N, Triche TJ, Wu L (2004) MAT1-modulated cyclin-dependent kinase-activating kinase activity cross-regulates neuroblastoma cell G1 arrest and neurite outgrowth. Cancer Res. 64, 2977-2983.
46. Shimizu T, Awai N, Takeda K (2000) Complex regulation of CDKs and G1 arrest during the granulocytic differentiation of human myeloblastic leukemia ML-1 cells. Oncogene 19, 4640-4646.
47. Dimberg A, Bahram F, Karlberg I, Larsson LG, Nilsson K, Oberg F (2002) Retinoic acid-induced cell cycle arrest of human myeloid cell lines is associated with sequential down-regulation of c-Myc and cyclin E and posttranscriptional up-regulation of p27(Kip1). Blood 99, 2199-2206.
48. Dow R, Hendley J, Pirkmaier A, Musgrove EA, Germain D (2011) Retinoic acid-mediated growth arrest requires ubiquitylation and degradation of the F-box protein Skp2. J. Biol. Chem. 276, 45945-45951.
49. Matsuo T, Thiele CJ (1998) P27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line. Oncogene 16, 3337-3343.
50. Oliva A, Borriello A, Zeppetelli S, Di Feo A, Cortellazzi P, Ventriglia V et al. (2003) Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol. Cell. Biochem. 247, 55-60.
51. Malik YS, Sheikh MA, Lai M, Cao R, Zhu X (2013) RING finger protein 10 regulates retinoic acid-induced neuronal differentiation and the cell cycle exit of P19 embryonic carcinoma cells. J. Cell. Biochem. 114, 2007-2015.
52. Wainwright LJ, Lasorella A, Iavarone A (2001) Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc. Natl Acad. Sci. USA 98, 9396-9400.
53. Borriello A, Cucciolla V, Criscuolo M, Indaco S, Oliva A, Giovane A et al. (2006) Retinoic acid induces p27KIP1 nuclear accumulation by modulating its phosphorylation. Cancer Res. 66, 4242-4248.
54. Radu M, Soprano DR, Soprano KJ (2008) S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines. J. Cell. Physiol. 217, 588-568.
55. Wang XS, Gong JN, Yu J, Wang F, Zhang XH, Yin XL et al. (2012) MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 119, 4992-5004.
56. Chen Q, Ross AC (2004) Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp. Cell Res. 297, 68-81.
57. Langenfeld J, Lonardo F, Kiyokawa H, Passalaris T, Ahn MJ, Rusch V et al. (1996) Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Oncogene 13, 1983-1990.
58. Fang Y, Zhou X, Lin M, Zhong L, Ying M, Luo P et al. (2010) The ubiquitin-proteasome pathway plays an essential role in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation. Cancer Biol. Ther. 10, 1157-1167.
59. Santamaría D, Barrière C, Cerqueira A, Hunt S, Tardy C, Newton K et al. (2007) Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448, 811-815.
60. Hedblom A, Laursen KB, Miftakhova R, Sarwar M, Anagnostaki L, Bredberg A et al. (2013) CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia. Cell Cycle 12, 1251-1266.
61. Nevins JR (2001) The Rb/E2F pathway and cancer. Hum. Mol. Genet. 10, 699-703.
62. Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25, 5277-5285.
63. Chen PL, Scully P, Sheng JY, Wang JYJ, Lee WH (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 1193-1198.
64. Mihara K, Cao XR, Yen A, Chandler S, Driscoll B, Murphree AL et al. (1989) Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246, 1300-1303.
65. Juan G, Li X, Darzynkiewicz Z (1998) Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation. Exp. Cell Res. 244, 83-92.
66. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Zhong S et al. (2001) PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb. J. Biol. Chem. 276, 43491-43494.
67. Watanabe Y, Watanabe T, Kitagawa M, Taya Y, Nakayama K, Motoyama N (1999) pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells. Brain Res. 842, 342-350.
68. Jacob C, Grabner H, Atanasoski S, Suter U (2008) Expression and localization of Ski determine cell type-specific TGFbeta signaling effects on the cell cycle. J. Cell Biol. 182, 519-530.
69. Xu B, Liu P, Li J, Lu H (2009) All-trans retinoic acid induces Thrombospondin-1 expression in acute promyelocytic leukemia cells though down-regulation of its transcription repressor, c-Myconcoprotein. Biochem. Biophys. Res. Commun. 382, 790-794.
70. Nishioka C, Ikezoe T, Yang J, Gery S, Koeffler HP, Yokoyama A (2009) Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells. Int. J. Cancer 125, 1710-1720.
71. Imran M, Park TJ, Lim IK (2012) TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid. Eur. J. Cancer 48, 2474-2485.
72. Bruel A, Touhami-Carrier M, Thomaidis A, Legrand C (2005) Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis. Anticancer Res. 2A, 757-764.
73. Lim IK, Lee MS, Ryu MS, Park TJ, Fujiki H, Eguchi H et al. (1998) Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol. Carcinog. 23, 25-35.
74. Uribesalgo I, Buschbeck M, Gutiérrez A, Teichmann S, Demajo S, Kuebler B et al. (2011) E-box-independent regulation of transcription and differentiation by MYC. Nat. Cell Biol. 13, 1443-1449.
75. Uribesalgo I, Benitah SA, Di Croce L (2012) From oncogene to tumor suppressor: the dual role of Myc in leukemia. Cell Cycle 11, 1757-1764.
76. Ertesvag A, Engedal N, Naderi S, Blomhoff HK (2002) Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion. J. Immunol. 169, 5555-5563.
77. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153.
78. Yang J, Ikezoe T, Nishioka C, Ni L, Koeffler HP, Yokoyama A (2010) Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1, 25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo. Exp. Hematol. 38, 666-676.
79. Seol JG, Park WH, Kim ES, Jung CW, Binderup L, Koeffler HP et al. (2000) Effect of a novel vitamin D3 analog, EB1089, on G1cell cycle regulatory proteins in HL-60 cells. Int. J. Oncol. 16, 315-320.
80. Thompson T, Danilenko M, Vassilev L, Studzinski GP (2010) Tumor suppressor p53 status does not determine the differentiation-associated G1 cell cycle arrest induced in leukemia cells by 1, 25-dihydroxyvitamin D and antioxidants. Cancer Biol. Ther. 10, 344-350.
81. Wang QM, Jones JB, Studzinski GP (1996) Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1, 25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 56, 264-267.
82. Matsumoto T, Sowa Y, Ohtani-Fujita N, Tamaki T, Takenaka T, Kuribayashi K et al. (1998) p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3. Cancer Lett. 129, 61-68.
83. Jensen SS, Madsen MW, Lukas J, Binderup L, Bartek J (2001) Inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery. Mol. Endocrinol. 15, 1370-1380.
84. Scaglione-Sewell BA, Bissonnette M, Skarosi S, Abraham C, Brasitus TA (2000) A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Endocrinology 141, 3931-3939.
85. Moffatt KA, Johannes WU, Hedlund TE, Miller GJ (2001) Growth inhibitory effects of 1alpha, 25-dihydroxyvitamin D(3) are mediated by increased levels of p21 in the prostatic carcinoma cell line ALVA-31. Cancer Res. 61, 7122-7129.
86. Wang X, Gocek E, Liu CG, Studzinski GP (2009) MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1, 25-dihydroxyvitamin D3. Cell Cycle 8, 736-741.
87. Boyle BJ, Zhao XY, Cohen P, Feldman D (2001) Insulin-like growth factor binding protein-3 mediates 1 alpha, 25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. J. Urol. 165, 1319-1324.
88. Rots NY, Iavarone A, Bromleigh V, Freedman LP (1999) Induced differentiation of U937 cells by 1, 25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression. Blood 93, 2721-2729.
89. Wang X, Gocek E, Novik V, Harrison JS, Danilenko M, Studzinski GP (2010) Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and up-regulates p27Kip1 concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1, 25-dihydroxyvitamin D(3). Cell Cycle 9, 4542-4551.
90. Bergh G, Telleus A, Fritzon A, Kornfält S, Johnson E, Olsson I et al. (2001) Forced expression of the cyclin-dependent kinase inhibitor p16(INK4A) in leukemic U-937 cells reveals dissociation between cell cycle and differentiation. Exp. Hematol. 29, 1382-1391.
91. 1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 278, 46862-46868.
92. Liu Q, Vanhoy RW, Zhou JH, Dantzer R, Freund GG, Kelley KW (1999) Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages. Mol. Cell. Biol. 19, 6229-6239.
93. Flores O, Wang Z, Knudsen KE, Burnstein KL (2010) Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition. Endocrinology 151, 896-908.
94. Wang QM, Chen F, Luo X, Moore DC, Flanagan M, Studzinski GP (1998) Lowering of p27Kip1 levels by its antisense or by development of resistance to 1, 25-dihydroxyvitamin D3 reverses the G1 block but not differentiation of HL60 cells. Leukemia 12, 1256-1265.
95. Jian Y, Yan J, Wang H, Chen C, Sun M, Jiang J et al. (2005) Cyclin D3 interacts with vitamin D receptor and regulates its transcription activity. Biochem. Biophys. Res. Commun. 335, 739-748.
96. Park SJ, Kim M, Kim NH, Oh MK, Cho JK, Jin JY et al. (2008) Auranofin promotes retinoic acid- or dihydroxyvitamin D3-mediated cell differentiation of promyelocyticleukaemia cells by increasing histone acetylation. Br. J. Pharmacol. 154, 1196-1205.
97. Hu X, Cress WD, Zhong Q, Zuckerman KS (2000) Transforming growth factor β inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells. BBRC 276, 930-939.
98. Ji Y, Kutner A, Verstuyf A, Verlinden L, Studzinski GP (2002) Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle 1, 410-415.
99. Ji Y, Studzinski GP (2004) Retinoblastoma protein and CCAAT/enhancer-binding proteinbeta are required for 1, 25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. Cancer Res. 64, 370-377.
100. Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpoles S, Watson RJ et al. (2002) E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16, 933-947.
101. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA et al. (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16, 245-256.
102. Verlinden L, Eelen G, Beullens I, Van Camp M, Van Hummelen P, Engelen K et al. (2005) Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1, 25-dihydroxyvitamin D3. J. Biol. Chem. 280, 37319-37330.
103. Verlinden L, Eelen G, Van Hellemont R, Engelen K, Beullens I, Van Camp M et al. (2007) 1alpha, 25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130. J. Steroid Biochem. Mol. Biol. 103, 411-415.
104. Chiang KC, Yeh CN, Hsu JT, Yeh TS, Jan YY, Wu CT et al. (2013) Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo. Cell Cycle 12, 1316-1325.